Pill imprint codes and the 1993 rule behind them

When FDA published its pill-imprinting rule on Sept. 13, 1993, the agency estimated that 90 to 95 percent of prescription tablets and capsules already carried an imprint, along with about 70 percent of those sold over the counter. Twenty-three states had laws requiring imprints on prescription drugs, according to the final rule in the Federal Register¹.

FDA's rule made the practice universal and wrote down the reasons for it. "Poison control centers and others use imprinted drug codes to identify drug products in overdose emergencies," FDA wrote. Consumers and health professionals use them "to recognize whether a pharmacist has dispensed a different manufacturer's product or has incorrectly filled a prescription." Imprints could also help people spot tampering and help officials trace counterfeit and defective products, the agency said.

More than 30 years later, the few characters stamped or printed on a tablet remain the most dependable link between a loose pill and a specific product. Why the same generic can look different from one refill to the next is covered in our piece on why your pill changed color.

What 21 CFR 206 requires

Part 206 of FDA's regulations holds the rule. It applies to "all solid oral dosage form human drug products," section 206.1³ says, which takes in prescription, over-the-counter, biological and homeopathic products. A solid oral dosage form means "capsules, tablets, or similar drug products intended for oral use," per the definitions in section 206.3⁴.

Its core requirement sits in section 206.10(a)⁶. A covered product may not enter interstate commerce unless it is "clearly marked or imprinted with a code imprint that, in conjunction with the product's size, shape, and color, permits the unique identification of the drug product and the manufacturer or distributor of the product." Identifying the drug product, the rule adds, "requires identification of its active ingredients and its dosage strength." Homeopathic products only need an imprint that identifies the manufacturer and their homeopathic nature.

Manufacturers choose their own codes. Under 206.10(d)⁶, a code imprint can be any letter or number or combination of them, "including, e.g., words, company name, and National Drug Code," or a mark, symbol, logo or monogram. Letters and numbers are not required, but the rule encourages them as "a more effective means of identification than a symbol or logo by itself." A product that should be imprinted and is not "may be considered adulterated and misbranded and may be an unapproved new drug."

FDA originally intended a one-year phase-in. Drug companies argued that retooling equipment would take longer, and the agency settled on two years, according to a 1995 clarification notice². The requirement took effect on Sept. 13, 1995.

Four ways to mark a tablet, and how often labels use each

Section 206.3 defines the methods. A mark can be debossed (pressed below the surface), embossed (raised above it), engraved (cut into the finished surface) or printed with ink, and the rule counts all four as imprinting, per the definitions⁴. Prescription labels describe which method was used in their dosage-form and How Supplied sections.

GxRadar counted how often each term appears in the How Supplied sections of the 34,924 prescription label documents in the openFDA drug label dataset¹², updated Oct. 30, 2026. The total includes injectables, creams and other forms that carry no imprint, and one label can use more than one term.

Debossing is by far the most common description in the data. openFDA notes that its data are unvalidated, and wording varies from label to label, so the figures are best read as orders of magnitude.

Who is exempt

Section 206.7 lists the exceptions. Drugs used in clinical investigations are exempt, as are placebos made to copy them, along with drugs used in bioequivalence studies other than the brand reference product. So are radiopharmaceuticals and drugs "extemporaneously compounded by a licensed pharmacist" on a prescription for one patient, the regulation says⁵. That last exemption is one reason a compounded capsule may carry no code; our explainer on 503A and 503B compounding describes those pharmacies.

FDA can also grant an exemption when a product's "size, shape, texture, or other physical characteristics make imprinting technologically infeasible or impossible." Sponsors of drugs given only in controlled health care settings, such as physicians' offices and other health care facilities, and never handed to patients to take on their own, may ask for an exemption as well.

Where the imprint is recorded

A code is useful only if someone can look it up. Federal labeling rules make sure the description is published. Under 21 CFR 201.57⁷, the Dosage Forms and Strengths section of a prescription label must describe "the identifying characteristics of the dosage forms, including shape, color, coating, scoring, and imprinting," and the How Supplied section must include similar identifying details along with the National Drug Code.

Those details are also coded as data. Labels submitted to FDA in its Structured Product Labeling format carry product characteristics that DailyMed¹¹ displays in a table for each product. An allopurinol listing we checked showed color, score (as the number of pieces the tablet breaks into), shape, size in millimeters and the imprint code. Color comes from a fixed list. FDA's SPLCOLOR data standard⁸ allows 12 values, from black to turquoise, and says imprints, "regardless of their color, are not considered" when the color is assigned. NLM's SPL image guidelines⁹ ask for front and back views of each tablet, with "imprints, symbols, scores, and color patterns" in focus, in a 1024 by 768 pixel JPEG of no more than 150 kilobytes.

The National Drug Code and the imprint do different jobs. The NDC identifies a product and its package and is printed on the bottle. The imprint travels with the tablet after it leaves the bottle. Our guide to looking up a drug on DailyMed shows how to find a product's characteristics table.

After Pillbox

For years NLM ran Pillbox, a federal tool that let anyone search by imprint, color and shape. NLM retired Pillbox on Jan. 29, 2021¹⁰, including its websites, dataset, image library and APIs. Its final data and images remain available as static files for research and education, but NLM said they "will not be updated and should not be used for pill identification." The same notice said MedlinePlus and DailyMed "do not provide pill identification."

That leaves DailyMed suited to confirming a product someone can already name, by comparing the code on a tablet with the characteristics listed for that product. Identifying an unknown pill from scratch is a job for the dispensing pharmacist, who can match the imprint against the pharmacy's own record of what went into the bottle, or, in a possible poisoning, for poison control. OTC labels print that number in the overdose statement of the Drug Facts panel; the generic ibuprofen label in openFDA's data lists 1-800-222-1222.

A few questions are worth asking at the counter when a tablet's code does not match what a reader expects. Was a different manufacturer's product dispensed this time (a common, legal switch described in the pharmacist's role in generic substitution)? Does the code match the listing for that manufacturer? Are all the tablets in the bottle the same? Our script for talking to your pharmacist has more on raising questions at the counter.

The 1993 preamble noted that imprint codes let products be identified "by reference to several commercially available compendia." The federal rule still requires only that the code be unique in combination with size, shape and color, and it still leaves the choice of characters to each manufacturer.